VIDEO: Routine lab monitoring not necessary with long-term dupilumab for AD

In this video from AAD VMX 2021, Andrew Blauvelt, MD, MBA, discusses his presentation on the necessity of laboratory testing for adult patients on long-term dupilumab treatment for moderate to severe atopic dermatitis.